Prevalences of Other Non-Thyroid Autoimmune Diseases and Factor Associated with Their Presence in Ocular Myasthenia Gravis

References

• Dresser L, Woldarski R, Rezania K, et al. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021;10(11):2235. doi:10.3390/jcm10112235
   PubMed Web of Science ®Google Scholar
• Peeler CE, Lott LBD, Eggenberger ER, et al. Clinical utility of acetylcholine receptor antibody testing in ocular myasthenia gravis. JAMA Neurol. 2015;72(10):1170–1174. doi:10.1001/jamaneurol.2015.1444
   PubMed Web of Science ®Google Scholar
• Jaretzki AIII, Barohn RJ, Sanders DB, et al. Myasthenia gravis: recommendations for clinical research standards. task force of the medical scientific advisory board of the myasthenia gravis foundation of America. Neurology. 2000;55(1):16–23. doi:10.1212/WNL.55.1.16
   PubMed Web of Science ®Google Scholar
• Gabriele M, Gregorio S, Valentina D, et al. Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? J Neurol. 2021;268(5):1803–1807. doi:10.1007/s00415-020-10342-3
   PubMed Web of Science ®Google Scholar
• Amin S, Aung M, Malik H, et al. Myasthenia gravis and its association with thyroid diseases. Cureus. 2020;12(9):e10248. doi:10.7759/cureus.10248
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang B, Hao Y, et al. Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases. Front Immunol. 2023;14:e1223322. doi:10.3389/fimmu.2023.1223322
   PubMed Web of Science ®Google Scholar
• Vincenzo DS, Salvatore I, Massimiliano M, et al. Comorbidity in myasthenia gravis: multicentric, hospital-based, and controlled study of 178 Italian patients. Neurol Sci. 2024. doi:10.1007/s10072-024-07368-0
   Web of Science ®Google Scholar
• Kemchoknatee P, Arepagorn A, Srisombut T. Ocular manifestation and generalization after ocular onset in ocular myasthenia gravis: a 5-year analysis. Asian Pac J Allergy Immunol. 2021. doi:10.12932/AP-260521-1141
   PubMedGoogle Scholar
• Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–2686. doi:10.1002/art.34473
   PubMed Web of Science ®Google Scholar
• Shiboski SC, Shiboski CH, Criswell L, et al. American college of rheumatology classification criteria for sjogren’s syndrome: a data-driven, expert consensus approach in the sjogren’s international collaborative clinical alliance cohort. Arthritis Care Res. 2012;64(4):475–487.
   PubMed Web of Science ®Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–2581. doi:10.1002/art.27584
   PubMed Web of Science ®Google Scholar
• Rudwaleit M, Heijde DVD, Landewe R, et al. The development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–783. doi:10.1136/ard.2009.108233
   PubMed Web of Science ®Google Scholar
• Angum F, Khan T, Hussain A, et al. The prevalence of autoimmune disorders in women: a narrative review. Cureus. 2020;12(5):e8094. doi:10.7759/cureus.8094
   PubMed Web of Science ®Google Scholar
• Song Y, Zhou L, Chen Z, et al. Increased frequency of thymic T follicular helper cells in myasthenia gravis patients with thymoma. J Thorac Dis. 2016;8(3):314–322. doi:10.21037/jtd.2016.03.03
   PubMed Web of Science ®Google Scholar
• Tian J, Zhang D, Yao X, et al. The global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modeling study. Ann Rheum Dis. 2023;82(3):351–356. doi:10.1136/ard-2022-223035
   PubMed Web of Science ®Google Scholar
• Qin B, Wang J, Yang Z, et al. Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983–1989. doi:10.1136/annrheumdis-2014-205375
   PubMed Web of Science ®Google Scholar
• Black RJ, Cross M, Haile LM, et al. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the global burden of disease study 2021. Lancet Rheumatol. 2023;5(10):e594–e610. doi:10.1016/S2665-9913(23)00211-4
   PubMedGoogle Scholar
• Stolwijk C, Onna MV, Boonen A, et al. Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis. Arthritis Care Res. 2016;68(9):1320–1331. doi:10.1002/acr.22831
   PubMed Web of Science ®Google Scholar
• Bekircan-Kurt CE, Kurne AT, Erdem-Ozdamar S, et al. The course of myasthenia gravis with systemic lupus erythematosus. Eur Neurol. 2014;72(5–6):326–329. doi:10.1159/000365568
   PubMed Web of Science ®Google Scholar
• Hrycek A. Systemic lupus erythematosus and myasthenia gravis. Pol Arch Med Wewn. 2009;119(9):582–585.
   PubMed Web of Science ®Google Scholar
• Meraouna A, Cizeron-Clairac G, Panse RL, et al. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood. 2006;108(2):432–440. doi:10.1182/blood-2005-06-2383
   PubMed Web of Science ®Google Scholar
• Ali M, Riad M, Adhikari P, et al. Association between myasthenia gravis and systemic lupus erythematosus as a comorbid state. Cureus. 2021;13(4):e14719. doi:10.7759/cureus.14719
   PubMed Web of Science ®Google Scholar
• Xue K, Niu WQ, Cui Y. Association of HLA-DR3 and HLA-DR15 polymorphisms with risk of systemic lupus erythematosus. Chin Med J. 2018;131(23):2844–2851.
   PubMed Web of Science ®Google Scholar
• Kwon YC, Chun S, Kim K, et al. Update on the genetics of systemic lupus erythematosus: genome-wide association studies and beyond. Cells. 2019;8(10):1180. doi:10.3390/cells8101180
   PubMed Web of Science ®Google Scholar
• Bubuioc AM, Kudebayeva A, Turuspekova S, et al. The epidemiology of myasthenia gravis. J Med Life. 2021;14(1):7–16. doi:10.25122/jml-2020-0145
   PubMedGoogle Scholar
• Avidan N, Panse RL, Berrih-Aknin S, et al. Genetic basis of myasthenia gravis – a comprehensive review. J Autoimmun. 2014;52:146–153. doi:10.1016/j.jaut.2013.12.001
   PubMed Web of Science ®Google Scholar
• Mao ZF, Yang LX, Mo XA, et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci. 2011;121(3):121–129. doi:10.3109/00207454.2010.539307
   PubMed Web of Science ®Google Scholar